ArticleNPJ digital medicine2026
Enhancing ocular sign detection: AI-based strategic segmentation for improved accuracy and privacy protection.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- ProptoView: AI-based digital exophthalmometry using multi-view facial images in a multinational validation study.Journal of translational medicine · 2026Article
- Centering the marginalized: AI-driven strategies for advancing health equity in rare disease care.Patterns (New York, N.Y.) · 2026Review
- Benchmarking clinical knowledge and multi-modal reasoning of large language models in liver cirrhosis.Scientific reports · 2026Article
- Management of Thyroid Eye Disease: A Comparison Between Three Recent Clinical Guidelines.Ophthalmology and therapy · 2026Review
- Sequential sensitivity analysis of multimodal large language models for rare orbital disease detection.Communications medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Accurate detection of ocular signs is essential for early diagnosis of eye diseases, but current AI approaches using facial or external ocular images include non-essential information, compromising performance and patient privacy. We conducted a multinational retrospective study of 2360 eyes from 1180 half-face images of thyroid eye disease patients across five racial groups from five hospitals in three countries. We developed a Dense Squeeze-and-Excitation Network (DSE-Net) to segment eyelid, conjunctiva, lacrimal caruncle, and eyeball, minimizing exposure and enhancing privacy. DSE-Net achieved Dice coefficient of 84.7%, 84.8%, 92.7%, and 95.1%, outperforming seven segmentation models. We then built SegmenView, employing LeNet, AlexNet, ResNet50, and VGGNet16 to detect eyelid edema, conjunctival erythema, caruncle or plica edema, and exophthalmos. SegmenView achieved internal Area Under the Curve (AUCs) of 71.09%, 80.81%, 90.07%, and 82.86%; external AUCs ranging 55.58%-84.29% across two test datasets, outperforming half-face and periocular models. We also compared SegmenView with four privacy-preserving methods, showing its superior ability to balance privacy protection with diagnostic accuracy. Additionally, visualizations based on Gradient-weighted Class Activation Mapping (Grad-CAM) further enhanced the model's interpretability. Our approach demonstrates high accuracy, generalizability, and potential for lightweight, privacy-preserving ocular sign detection.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.